Amine-functionalized polymeric compositions for medical devices

US9861723B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9861723-B2
Application numberUS-201715491228-A
CountryUS
Kind codeB2
Filing dateApr 19, 2017
Priority dateOct 24, 2012
Publication dateJan 9, 2018
Grant dateJan 9, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure provides amine-modified polymer foams, which may be used for wound dressing materials. For example, the modified materials can include a covalently attached molecule comprising free amine groups. Such amine groups can be used, for instance, to conjugate biologically active polypeptides and/or linkers. Methods for using modified polymers are also provided.

First claim

Opening claim text (preview).

What is claimed is: 1. A wound dressing comprising an amine-functionalized polymer foam and a biologically active agent covalently attached to an amine group on the polymer foam. 2. The wound dressing of claim 1 , wherein the biologically active agent is attached to the foam through an adapter. 3. The wound dressing of claim 1 , wherein the biologically active agent is a polypeptide. 4. The wound dressing of claim 3 , wherein the polypeptide is selected from the group consisting of gelatin, collagen, albumin, an enzyme, growth factor, chemokine, cytokine, and a polypeptide that binds to any of them. 5. The wound dressing of claim 4 , wherein the polypeptide is an enzyme selected from a protease, hydrolase, lyase, ligase, isomerase, transferase, oxidase, reductase, oxidoreductase, synthase, polymerase, kinase, and phosphatase. 6. The wound dressing of claim 1 , comprising a polyurethane foam. 7. The wound dressing of claim 6 , comprising an open cell foam. 8. The wound dressing of claim 1 , wherein the amine-functionalized polymer foam comprises a polyurethane polymer copolymerized with neomycin. 9. The wound dressing of claim 1 , wherein the biologically active agent is directly attached to the functionalized polymer foam. 10. The wound dressing of claim 2 , wherein the adapter is an amine to amine crosslinker. 11. The wound dressing of claim 10 , wherein the amine-to-amine crosslinker is selected from malondialdehyde, succinaldehyde, phthalaldehyde, glutaraldehyde, and glyoxal. 12. The wound dressing of claim 11 , wherein the crosslinker is glutaraldehyde. 13. The wound dressing of claim 2 , wherein the adapter is cleavable. 14. The wound dressing of claim 7 , wherein the material comprises a foam that is a reticulated open-celled foam. 15. A method for treating a wound site, comprising: applying a wound dressing according to claim 1 to a wound site; and applying negative pressure to the wound site. 16. The method of claim 15 , further comprising applying an instillation solution to the wound site. 17. The method of claim 15 , wherein the biologically active agent comprises a polypeptide. 18. The method of claim 16 , wherein the instillation solution includes one or more agents that modulate a release of the biologically active agent. 19. The wound dressing of claim 1 , wherein the biologically active agent comprises a debridement enzyme. 20. The wound dressing according to claim 19 , wherein the biologically active agent is bromelain. 21. The wound dressing according to claim 19 , wherein the biologically active agent is papain. 22. The wound dressing according to claim 19 , wherein the biologically active agent is trypsin. 23. The wound dressing according to claim 19 , wherein the biologically active agent is collagenase.

Assignees

Inventors

Classifications

  • Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof (mechanical aspects of shaping of plastics or substances in a plastic state for the production of porous or cellular articles B29C) · CPC title

  • comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic (drug delivery dressings A61K9/70; chemical aspect of the additives A61L15/00) · CPC title

  • Porous materials, e.g. foams or sponges · CPC title

  • Antibiotics · CPC title

  • Human Necessities · mapped topic

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9861723B2 cover?
The present disclosure provides amine-modified polymer foams, which may be used for wound dressing materials. For example, the modified materials can include a covalently attached molecule comprising free amine groups. Such amine groups can be used, for instance, to conjugate biologically active polypeptides and/or linkers. Methods for using modified polymers are also provided.
Who is the assignee on this patent?
Kci Licensing Inc
What technology area does this patent fall under?
Primary CPC classification A61L26/0066. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jan 09 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).